(Q38682721)

5 September 2017

1 reference

title

Adverse effects of amiodarone. Pathogenesis, incidence and management (English)

1 reference

5 September 2017

1 reference

amiodarone

15 June 2024

G V Naccarelli

1

1 reference

5 September 2017

R L Rinkenberger

series ordinal

2

1 reference

5 September 2017

A H Dougherty

series ordinal

3

1 reference

5 September 2017

D M Fitzgerald

series ordinal

4

1 reference

5 September 2017

publication date

1 July 1989

1 reference

Medical toxicology and adverse drug experience

5 September 2017

published in

1 reference

5 September 2017

volume

4

1 reference

5 September 2017

issue

4

1 reference

5 September 2017

page(s)

246-253

1 reference

Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Side effects and possible contraindications of amiodarone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Ocular effects in long-term amiodarone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Drug interactions with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Adverse reactions during treatment with amiodarone hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Side effects and complications of amiodarone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Amiodarone pulmonary toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Ten years of experience with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Amiodarone-induced polymorphous ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Dangerous interaction between amiodarone and quinidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Amiodarone-induced ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03259911

Amiodarone pulmonary toxicity: Prospective evaluation of serial pulmonary function tests

21 January 2018

1 reference

12 December 2020

Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy

1 reference

12 December 2020

Amiodarone therapy during pregnancy

1 reference

12 December 2020

Amiodarone: pharmacology and antiarrhythmic and adverse effects

1 reference

12 December 2020

Clinical use and pharmacology of amiodarone

1 reference

12 December 2020

Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications

1 reference

12 December 2020

The potentiation of warfarin anticoagulation by amiodarone

1 reference

12 December 2020

Effect of amiodarone on serum quinidine and procainamide levels

1 reference

12 December 2020

Amiodarone keratopathy. Correlation to dosage and duration

1 reference

12 December 2020

Flecainide and amiodarone interaction

1 reference

12 December 2020

Amiodarone pulmonary toxicity

1 reference

12 December 2020

Neuromyopathy during chronic amiodarone treatment. A case report

1 reference

12 December 2020

Amiodarone increases plasma digoxin concentrations

1 reference

12 December 2020

Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms

1 reference

12 December 2020

Pulmonary gallium-67 uptake in amiodarone pneumonitis

1 reference

12 December 2020

Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies

1 reference

12 December 2020

A Peculiar Cutaneous Pigmentation from Cordarone

1 reference

12 December 2020

Amiodarone hepatotoxicity simulating alcoholic liver disease

1 reference

12 December 2020

Chronic administration of amiodarone and thyroid function: a follow-up study

1 reference

12 December 2020

Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy

1 reference

12 December 2020

Interaction between warfarin sodium and amiodarone

1 reference

12 December 2020

Dangers of amiodarone and anticoagulant treatment

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03259911

1 reference

5 September 2017

1 reference